Menopause and Dry Eye
Dry eye is one of the most common — and most under-discussed — symptoms of menopause and perimenopause. The hormonal changes that drive hot flashes and sleep disruption also fundamentally alter how the eye produces and maintains its tear film. According to the TFOS DEWS II Sex, Gender, and Hormones Report, dry eye disease affects women at significantly higher rates than men across nearly every age group, with the largest gap appearing during and after menopause. Dr. Y. Shira Kresch evaluates and treats hormonal dry eye at our Southfield, MI clinic.
If you noticed your eyes becoming chronically dry, burning, or visually unstable around the same time other menopausal symptoms started, you are not imagining the connection. Hormonal dry eye is a well-documented clinical entity with specific mechanisms and specific treatments — and it is not something you have to live with.
How Menopause Causes Dry Eye
The Meibomian glands of the eyelids and the lacrimal glands that produce tears are both hormonally regulated tissues. They have androgen receptors (responding to testosterone and other male sex hormones) and estrogen receptors that influence their function. When hormone levels shift during perimenopause and menopause, both gland systems are affected.
Androgen Decline
Androgens (including testosterone) decline gradually starting in the 30s and more steeply during menopause. According to research summarized by AllAboutVision and peer-reviewed dry eye literature, androgens have a directly protective effect on Meibomian gland function — they support healthy meibum production and gland tissue integrity. As androgen levels fall, Meibomian gland function declines, contributing to evaporative dry eye.
Estrogen Changes
Estrogen has complex effects on the ocular surface. The relationship is not as simple as “more estrogen equals better tear film” — both estrogen excess and estrogen deficiency have been associated with dry eye in different patient populations. Estrogen-only hormone replacement therapy, in particular, has been associated with worsening dry eye in some studies.
Reduced Tear Production
The lacrimal glands also respond to sex hormone changes. Many women experience reduced aqueous tear production during menopause, contributing to the dry, gritty sensation that is particularly common in the morning and late evening.
Concurrent Meibomian Gland Dysfunction
The cumulative effect of these hormonal changes is a significant increase in the prevalence and severity of Meibomian Gland Dysfunction in women during and after menopause. MGD that develops in the 40s and 50s, particularly in women, is very frequently driven by hormonal mechanisms.
Symptoms of Menopause-Related Dry Eye
- Burning, stinging, or gritty sensation that started or worsened during perimenopause
- Eyes that feel worse in the morning, again at the end of the day
- Increased reflex tearing (paradoxically watery eyes)
- Fluctuating vision, particularly with reading or screen time
- Contact lens intolerance that developed in middle age
- Crusty debris on the eyelashes
- Light sensitivity
- Symptoms that fluctuate with hot flashes or sleep quality
Hormone Replacement Therapy and Dry Eye
The relationship between hormone replacement therapy (HRT) and dry eye is more complex than it might seem. Some patients experience improvement in dry eye on combined estrogen-progesterone HRT; others experience worsening. Estrogen-only HRT is associated with worsening dry eye in some studies.
If you are taking HRT and experiencing dry eye symptoms, the conversation about whether to adjust your hormones should happen between you, your gynecologist or primary care physician, and ideally a dry eye specialist who can document the ocular effects. Do not adjust HRT unilaterally based on eye symptoms alone — the systemic implications matter.
How We Diagnose Menopause-Related Dry Eye
A comprehensive dry eye evaluation for a patient with suspected hormonal dry eye includes:
- Symptom history — including menopause/perimenopause timing, current HRT use, other hormonal medications
- Meibography — to assess Meibomian gland structure and atrophy
- Tear film breakup time and osmolarity
- Meibomian gland expression assessment — quality and quantity of meibum
- Ocular surface staining — to identify damage patterns
- Schirmer test — to differentiate evaporative from aqueous-deficient components
How We Treat Menopause-Related Dry Eye
In-Office Treatments for MGD
Because most menopause-related dry eye involves significant Meibomian gland dysfunction, in-office treatments are often the most effective intervention. IPL, RF, and LLLT address the underlying gland dysfunction directly. The combined treatment protocol is particularly effective for moderate-to-severe cases.
Anti-Inflammatory Therapy
Prescription anti-inflammatory drops help control the chronic ocular surface inflammation that develops in long-standing hormonal dry eye.
Lifestyle Adjustments
Hydration, omega-3 supplementation, screen time management, environmental humidification, and lid hygiene all contribute meaningfully. None are sufficient on their own for moderate-to-severe cases.
Coordination with Your GYN/Primary Care
For patients on HRT, we communicate with your prescribing physician when relevant — particularly if HRT adjustments might be appropriate based on the dry eye findings.
Why Women Develop Dry Eye More Often Than Men
Even outside of menopause, women experience dry eye at higher rates than men. According to the TFOS DEWS II Sex, Gender, and Hormones Report, this gap exists across most adult age groups but is most pronounced in the perimenopausal and postmenopausal years. Hormonal mechanisms drive most of this difference. See also our page on why dry eye affects women.
Frequently Asked Questions
Q: Will my dry eye get better after menopause is over? Generally no. The hormonal changes of menopause are not reversed — they continue indefinitely. Without treatment, postmenopausal dry eye tends to be progressive.
Q: Should I take hormone replacement therapy for my dry eye? HRT decisions should be made based on overall menopause management with your gynecologist or primary care provider, not based on eye symptoms alone. Some HRT regimens help dry eye, others worsen it. Eye-specific treatments (IPL, RF, prescription drops) usually produce more reliable improvement than relying on HRT for dry eye management.
Q: I am only in perimenopause. Why do I have such severe dry eye already? Perimenopausal hormone fluctuations can be more disruptive than the relatively stable hormone state of full menopause. Many women experience their worst dry eye during the perimenopausal years.
Q: Will artificial tears be enough? For mild cases, sometimes. For moderate-to-severe hormonal dry eye driven by Meibomian gland dysfunction, artificial tears help symptomatically but do not address the underlying gland dysfunction. Eye-specific in-office treatment is usually necessary for lasting improvement.
Q: How quickly will I notice treatment results? Many patients notice improvement after the first or second IPL/RF session. Cumulative benefit builds through the treatment series. Maintenance treatments every 6 to 12 months preserve long-term results.
Q: Will insurance cover treatment? The diagnostic evaluation is typically covered by medical insurance. In-office treatments are generally considered elective and not covered. We discuss cost transparently before treatment begins.
Q: Are my symptoms related to other menopause symptoms? Yes — many women report worse dry eye during hot flashes, after poor sleep, or during particularly difficult perimenopausal phases. The underlying hormonal mechanisms are connected.